Abstract
Kaposi’s sarcoma (KS) is a proliferative disease of vascular origin and is the most frequent tumor of human immunodeficiency virus type 1 (HIV-1)-infected individuals, particularly of homosexual and bisexual men (Friedman-Kien et al., 1981; Havercos et al., 1985; Safai et al., 1985). In patients with acquired immunodeficiency syndrome (AIDS), KS (AIDS-KS) generally has an aggressive and rapid course that is characterized by widely distributed skin lesions, and early dissemination to visceral organs (Safai et al., 1985; Gottlieb and Ackerman, 1982). Other clinical types of KS include classical KS, an indolent disease that affects the lower extremities of elderly men of Mediterranean origin. Iatrogenic KS occurs in 5% of recipients of solid organ transplants, especially those taking glucocorticoids for immune suppression. Endemic KS occurs primarily in men of sub-Saharan Africa origin (Taylor et al., 1972; Slavin et al., 1969).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Aboulafia, D., Miles, S. A., Saks, S. R., and Mitsuyasu, R. T., 1989, Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi’s sarcoma, J. Acq. Immune Defic. Syndr. 2:54–58.
Barillari, G., Buonaguro, L., Fiorelli, V., Hoffman, J., Michaels, F., Gallo, R. C., and Ensoli, B., 1992, Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: Implications for AIDS-Kaposi’s sarcoma pathogenesis, J. Immunol. 149:3727–3734.
Barillari, G., Gendelman, R., Gallo, R. C., and Ensoli, B., 1993, The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing RGD amino acid sequence, Proc. Natl. Acad. Sci. USA 90:7941–7945.
Biasco, G., Paganelli, G. M., Miglioli, M., Brillanti, S., DiFebo, G., Gizzi, G., Ponz de Leon, M., Campieri, M., and Barbara, L., 1990, Rectal cell proliferation and colon cancer risk in ulcerative colitis, Cancer Res. 50:1156–1159.
Brock, T. A., Dvork H. F., and Senger, D. R., 1991, Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells, Am. J. Pathol. 138:213–221.
Brooks, P. C., Clark, R. A. F., and Cheresh, D. A., 1994, Requirement of vascular integrin αvβ3 for angiogenesis, Science 264:569–571.
Browning, P. J., Roberts, D. D., Zabrenetzky, V., Bryant, J., Kaplan, M., Washington, R. H., Panet, A., Gallo, R. C., and Vogel, T., 1994a, Apolipoprotein E (Apo E), a novel heparin-binding protein inhibits the development of Kaposi’s sarcoma-like lesions in Balb/c nu/nu mice, J. Exp. Med. 180:1949–1954.
Browning, P. J., Sechler, J. M., Kaplan, M., Washington, R. H., Gendelman, R., Ensoli, B., and Gallo, R. C., 1994b, Identification and culture of Kaposi’s sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls, Blood 84:2711–2720.
Buonaguro, L., Buonaguro, F. M., Giraldo, G., and Ensoli, B., 1994, The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure, J. Virol. 68:2677–2682.
Cesarman, E., Chang, Y., Moore, P. S., Said, J. W., and Knowles, D. M., 1995, Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphoma, N. Engl. J. Med. 332:1186–1191.
Chang, H. K., Samaniego, F., Buonaguro, L., Nair, B. C., Gallo, R. C., and Ensoli, B., 1995, Extracellular Tat binds heparan sulfate complexes of the cell surface and extracellular matrix (ECM) through the basic region, AIDS Res. Hum. Retrovir. 11:S116.
Clark, E. A., and Brugge, J. S., 1995, Integrins and signal transduction pathways: The road taken, Science 268:233–239.
Corallini, A., Altavilla, G., Pozzi, L., Bignozzi, F., Negrini, M., Rimessi, P., Gualandi, F., and Barbanti-Brodano, G., 1993, Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes, Cancer Res. 53:5569–5575.
Damsky, C. H., and Werb, Z., 1992, Signal transduction by integrin receptors for extracellular matrix: Cooperative processing of extracellular information, Curr. Opin. Cell Biol. 4:772–781.
Delli Bovi, P., Donti, E., Knowles, D. M., Friedman-Kien, A., Luciw, P. A., Dina, D., Dalla-Favera, R., and Basilico, C., 1986, Presence of chromosomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS-associated Kaposi’s sarcoma, Cancer Res. 46:6333–6338.
Ensoli, B., Nakamura, S., Salahuddin, S. Z., Biberfeld, P., Larsson, L., Beaver, B., Wong-Staal, F., and Gallo, R. C., 1989, AIDS-Kaposi’s sarcoma-derived cells express cytokines with autocrine and paracrine growth effects, Science 243:223–226.
Ensoli, B., Barillari, G., Salahuddin, S. Z., Gallo, R. C., and Wong-Staal, F., 1990, Tat protein of HIV-1 stimulates growth of AIDS-Kaposi’s sarcoma-derived cells, Nature 345:84–86.
Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R. A., Wingfeld, P., and Gallo, R. C., 1993, Release, uptake and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation, J. Virol. 67:277–287.
Ensoli, B., Gendelman, R., Markham, P., Fiorelli, V., Colombini, S., Raffeld, M., Cafaro, A., Chang, H. K., Brady, J. N., and Gallo, R. C., 1994a, Synergy between basic fibroblast growth factor and the HIV-1 Tat protein in induction of Kaposi’s sarcoma, Nature 371:674–680.
Ensoli, B., Markham, P., Kao, V., Barillari, G., Fiorelli, V., Gendelman, R., Raffeld, M., Zon, G., and Gallo, R. C., 1994b, Block of AIDS-Kaposi’s sarcoma (KS) cell growth, angiogenesis and lesion formation in nude mice by antisense oligonucleotides targeting basic fibroblast growth factor: A novel strategy for the therapy of KS, J. Clin. Invest. 94:1736–1746.
Fan, J., Bass, H. Z., and Fahey, J. L., 1993, Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV-1 infection, J. Immunol. 151:5031–5040.
Fidler, I. J., Singh, R. K., Gutman, M., Sanchez, R., and Bucana, C. D., 1994, Interferons a and β downregulate the expression of basic fibroblast growth factor (bFGF) in human carcinomas, Cancer Res. 35:57.
Fiorelli, V., Markham, P., Samaniego, F., Gendelman, R., and Ensoli, B., 1995, Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi’s sarcoma spindle cells, J. Clin. Invest. 95:1723–1734.
Folkman, J., and Klagsbrun, M., 1987, Angiogenic factors, Science 235:442–447.
Folkman; J., Klagsbrun, M., Sasse, J., Wadzinski, M., Ingber, D., and Vlodavsky, I., 1988, A heparin binding angiogenic protein basic fibroblast growth factor is stored within basement membrane, Am. J. Pathol. 130:393–400.
Friedman-Kien, A. E., 1981, Disseminated Kaposi’s sarcoma syndrome in young homosexual men, J. Am. Acad. Dermatol. 5:468–471.
Gottlieb, G. J., and Ackerman, A. B., 1982, Kaposi’s sarcoma: An extensively disseminated form in young homosexual men, Hum. Pathol. 13:882–886.
Havercos, H. W., Drotman, D. P., and Morgan, M., 1985, Prevalence of Kaposi’s sarcoma among patients with AIDS, N. Engl. J. Med. 312:1518–1520.
Hejna, W. F., 1965, Squamous cell carcinoma developing in the chronic draining sinus of osteomyelitis, Cancer 18:128–132.
Hemdier, B. G., Werner, A., Arnstein, P., Abbey, N. W., Demartis, F., Cohen, R. L., Shuman, M. A., and Levy, J. A., 1994, Characterization of a human Kaposi’s sarcoma cell line that induces angiogenic tumors in animals, AIDS 8:575–581.
Hofman, F. M., Wright, A. D., Dohadwala, M. M., Wong-Staal, F., and Walker, S. M., 1993, Exogenous tat protein activates human endothelial cells, Blood 82:2774–2780.
Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., and Folkman, J., 1990, Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth, Nature 348:555–557.
Jaffe, H. W., Choi, K., Thomas, P. A., Havercos, H. W., Auerbach, D. M., Guinan, M. E., Rogers, M. F., Spira, T. J., Darrow, W. W., Kramer, M. A., Friedman, S. M., Monroe, J. M., Friedman-Kien, A. E., Laubenstein, L. J., Marmor, M., Safai, B., Dritz, S. K., Crispi, S. J., Fannin, S. L., Orkwis, J. P., Kelter, A., Rushing, W. R., Thacker, S. B., and Curran, J. W., 1983, National case-control study of Kaposi’s sarcoma and Pneumocystis carinii pneumonia in homosexual men: part 1, epidemiological results, Ann. Intern. Med. 99:145–151.
Janier, M., Flageul, B., Drouet, L., Scobohaci, M. L., Villette, J. M., Palangie, A., and Cottenot, F., 1988, Cutaneous and plasma values of von Willebrand factor in AIDS: A marker of endothelial stimulation? Invest. Dermatol. 90:703–707.
Kandel, J., Bossy-Wetzel, E., Radvanyi, F., Klagsbrun, M., Folkman, J., and Hanahan, D., 1991, Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma, Cell 66:1095–1104.
Krigel, R. L., Odajnyk, C. M., Laubenstein, L. J., Ostreicher, R., Wernz, J., Vilcek, J., Rubinstein, P., and Friedman-Kien, A. E., 1985, Therapeutic trial of interferon-7 in patients with epidemic Kaposi’s sarcoma, J. Biol. Response Modif. 4:358–364.
Krown, S. E., 1987, The role of interferon in the therapy of epidemic Kaposi’s sarcoma, Semin. Oncol. 14:27–33.
Lahdevirta, J., Maury, C. P. J., Teppo, A. M., and Repo, H., 1988, Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome, Am. J. Med. 85:289–291.
Lepe-Zanuga, J. L., Mansell, P. W. A., and Hersh, E. M., 1987, Idiopathic production of interleukin-1 in acquired immune deficiency syndrome, J. Clin. Microbiol. 25:1695–1699.
Lunardi-Iskandar, Y., Bryant, J. L., Zeman, R. A., Lam, V. H., Samaniego, F., Besnier, J. M., Hermans, P., Thierry, A. R., Gill, P., and Gallo, R. C., 1995a, Tumorigenesis and metastasis of neoplastic Kaposi’s sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone, Nature 375:64–68.
Lunardi-Iskandar, Y., Gill, P., Lam, V. H., Zeman, R. A., Michaels, F., Mann, D. L., Reitz, M. S., Jr., Kaplan, M., Berneman, Z. N., Carter, D., Bryant, J. L., and Gallo, R. C., 1995b, Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi’s sarcoma, J. Natl. Cancer Inst. 87:974–981.
Mahoney, S. E., Duvic, M., Nickoloff, B. J., Minshall, M., Smith, L. C., Griffiths, C. E. M., Paddock, S. W., and Lewis, D. E., 1991, Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi’s sarcoma lesions, J. Clin. Invest. 88:174–185.
Marcuzzi, A., Weinberger, J., and Weinberger, O. K., 1992, Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes, J. Virol. 66:4228–4231.
Miles, S. A., Rezai, A. R., Salazar-Gonzalez, J. F., VanderMeyden, M., Stevens, R. H., Logan, D. M., Mitsuyasu, R. T., Taga, T., Hirano, T., Kishimoto, T., and Martinez-Maza, O., 1990, AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6, Proc. Natl. Acad. Sci. USA 87:4068–4072.
Miles, S.A., Martinez-Maza, O., Rezai, A., Maypantay, L., Kishimoto, T., Nakamura, S., Radka, S. F., and Linsey, P. S., 1992, Oncostatin M as a potent mitogen for AIDS-KS-derived cells, Science 255:1432–1434.
Mitsuyasu, R. T., 1991, Interferon alpha in the treatment of AIDS-related Kaposi’s sarcoma, Br. J. Haematol. 79:69–71.
Mitsuyasu, R. T., 1994, Clinical aspects of AIDS-related Kaposi’s sarcoma, in: Current Review of Oncology (M. D. Abeloff and J. Klastersky, eds.), Current Science, Baltimore, pp. 835–844.
Moore, P. S., and Chang, Y., 1995, Detection of herpesvirus-like DNA sequences in Kaposi’s sarcoma in patients with and those without HIV infection, N. Engl. J. Med. 332:1181–1185.
Nadji, M., Morales, A. R., Ziegles-Weissman, J., and Penneys, N. S., 1981, Kaposi’s sarcoma: Immunohistologic evidence for an endothelial origin, Arch. Pathol Lab. Med. 105:274–275.
Nair, B. C., DeVico, A. L., Nakamura, S., Copeland, T. D., Chen, Y., Patel, A., O’Neil, T., Oroszlan, S., Gallo, R. C., and Sarngadharan, M. G., 1992, Identification of a major growth factor for AIDS-Kaposi’s sarcoma cells as oncostatin M., Science 255:1430–1432.
Nakamura, S., Salahuddin, S. Z., Biberfeld, P., Ensoli, B., Markham, P. D., Wong-Staal, R., and Gallo, R. C., 1988, Kaposi’s sarcoma cells: Long-term culture with growth factor from retrovirus-infected CD4+ T cells, Science 242:426–430.
Nakamura, S., Sakurada, S., Salahuddin, S. Z., Osada, Y., Tanaka, N. G., Sakamoto, N., Sekiguchi, M., and Gallo, R. C., 1992, Inhibition of development of Kaposi’s sarcoma-related lesions by a bacterial cell wall complex, Science 255:1437–1440.
Orfanos, C. E., Husak, R., Wolfer, U., and Garbe, C., 1995, Kaposi’s sarcoma: A reevaluation, Recent Results Cancer Res. 139:275–296.
Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R., 1992, Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro, Biochem. Biophys. Res. Commun. 189:824–831.
Pober, J. S., and Cotran, R. S., 1990, Cytokines and endothelial cell biology, Physiol. Rev. 70:427–451.
Rabkin, C. S., Bedi, G., Musaba, E., Sunkutu, R., Mwansa, N., Sidransky, D., and Biggar, R. J., 1995, AIDS-related Kaposi’s sarcoma is a clonal neoplasm, Clin. Cancer Res. 1:257–260.
Regezi, J. A., MacPhail, L. A., Daniels, T. E., DeSouza, Y. G., Greenspan, J. S., and Greenspan, D., 1993, Human immunodeficiency virus-associated oral Kaposi’s sarcoma: A heterogeneous cell population dominated by spindle-shaped endothelial cells, Am. J. Pathol. 43:240–249.
Roth, W. K., Werner, S., Schirren, C. G., and Hofschneider, P. H., 1989, Depletion of PDGF from serum inhibits growth of AIDS-related and sporadic Kaposi’s sarcoma cells in culture, Oncogene 4:483–487.
Ruszczak, Z., Mayer-Da Silva, A., and Orfanos, C. E., 1987a, Kaposi’s sarcoma in AIDS: Multicentric angio-neoplasia in early skin lesions, Am. J. Dermatopathol. 9:388–398.
Ruszczak, Z., Mayer-Da Silva, A., and Orfanos, C. E., 1987b, Angioproliferative changes in clinically non-involved, perilesional skin in AIDS-associated Kaposi’s sarcoma, Dermatologica 175:270–279.
Safai, B., Johnson, K. G., Myskowski, P. L., Koziner, B., Yang, S. Y., Cunningham-Rundles, S., Godbold, J. H., and Dupont, B., 1985, The natural history of Kaposi’s sarcoma in the acquired immunodeficiency syndrome, Ann. Intern. Med. 103:744–750.
Salahuddin, S. Z., Nakamura, S., Biberfeld, P., Kaplan, M. H., Markham, P. D., Larsson, L., and Gallo, R. C., 1988, Angiogenic properties of Kaposi’s sarcoma-derived cells after long-term culture in vitro, Science 242:430–433.
Samaniego, F., Bryant, J. L., Lam, V. J., Zeman, R. A., Thierry, A., Judde, J. G., and Gallo, R. C., 1995a, Human chorionic gonadotropin (hCG) prevents development of Kaposi’s sarcoma (AIDS-KS Y-1) tumors by inducing apoptosis, AIDS Res. Hum. Retrovir. 11:S76.
Samaniego, F., Chang, H.-K., Gallo, R. C., and Ensoli, B., 1995b, HIV Tat protein induces signal transduction in AIDS-Kaposi’s sarcoma and cytokine-activated endothelial cell. Presented at Signal Transductions of Normal and Tumor Cells Meeting, Cancer Res. p. A24.
Samaniego, F., Markham, P., Gallo, R. C., and Ensoli, B., 1995c, Inflammatory cytokines induce AIDS-Kaposi’s sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi’s sarcoma-like lesion formation in nude mice, J. Immunol 154:3582–3592.
Samaniego, F., Markham, P. D., Sturzl, M., Gendelman, R., Ferrara, N., Kao, V., Kowalski, K., Ensoli, B., and Gallo, R. C., 1995d, Vascular endothelial growth factor (VEGF) is expressed by AIDS-Kaposi’s sarcoma (KS) cells and synergizes with bFGF to form KS-like lesions in nude mice, AIDS Res. Hum. Retrovir. 11:S95.
Samaniego, F., Markham, P. D., Gendelman, R., Gallo, R. C., and Ensoli, B., 1996, Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi’s sarcoma-like lesions in nude mice, (submitted for publication).
Schlaepfer, D. D., Hanks, S. K., Hunter, T., and van der Geer, P., 1994, Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase, Nature 372:786–791.
Sciacca, F. L., Sturzl, M., Bussolino, F., Sironi, M., Brandstetter, H., Zietz, C., Zhou, D., Matteucci, C., Peri, G., Sozzani, S., Benelli, R., Arese, M., Albini, A., Colotta, F., and Montovani, A., 1994, Expression of adhesion molecules platelet-activating factor, and chemokines by Kaposi’s sarcoma cells, J. Immunol. 153:4816–4825.
Siegal, B., Levinton-Kriss, S., Schiffer, A., Sayar, J., Egelberg, I., Vonsover, A., Ramon, Y., and Rubinstein, E., 1990, Kaposi’s sarcoma in immunosuppression—Possibly the result of a dual viral infection, Cancer 65:492–496.
Singh, R. K., Liansa, N., Bucana, C. D., Sanchez, R., and Fidler, I. J., 1995, Cell density-dependent modulation of basic fibroblast growth factor expression by IFN-β, Proc. Am. Assoc. Cancer Res. 36:87.
Slavin, G., Cameron, H. M., and Singh, H., 1969, Kaposi’s sarcoma in mainland Tanzania: A report of 117 cases, Br. J. Cancer 23:349–357.
Taylor, J. F., Smith, P. G., Bull, D., and Pike, M. C., 1972, Kaposi’s sarcoma in Uganda: Geographic and ethnic distribution, Br. J. Cancer 6:483–497.
Vogel, J., Hinrichs, S. H., Reynolds, R. K., Luciw, P. A., and Jay, G., 1988, HIV-1 tat gene induces dermal lesions resembling Kaposi’s sarcoma in transgenic mice, Nature 335:606–611.
Werner, S., Hofschneider, P. H., Heldin, C. H., Östman, A., and Roth, W. K., 1990, Cultured Kaposi’s sarcoma-derived cells express functional PDGF-A type and B-type receptors, Exp. Cell Res. 187:98–103.
Yamamoto, T., Osaki, T., Yoneda, K., and Ueta, E., 1993, Immunological investigation of adult patients with primary herpes simplex virus-1 infection, J. Oral Pathol. Med. 22:263–267.
Yang, J., Xu, Y., Zhu, C., Hagan, M. K., Lawley, T., and Offermann, M. K., 1994, Regulation of adhesion molecular expression in Kaposi’s sarcoma cells, J. Immunol. 152:361–373.
Xerri, L., Haussoun, J., Planche, J., Guigou, V., Grob, J. J., Parc, P., Birnbaum, D., and Delapeyriere, O., 1991, Fibroblast growth factor gene expression in AIDS-Kaposi’s sarcoma detected by in situ hybridization, Am. J. Pathol. 138:9–15.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Samaniego, F., Gallo, R.C. (1996). Immunopathogenesis of Kaposi’s Sarcoma. In: Gupta, S. (eds) Immunology of HIV Infection. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0191-0_22
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0191-0_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0193-4
Online ISBN: 978-1-4899-0191-0
eBook Packages: Springer Book Archive